Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL17201543

Cc1nccc(-c2cnc(C(=O)O)s2)n1.O=C(O)C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SORT1 Q99523 2/20 0.37
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
AAK1 Q2M2I8 8/20 0.36
CDC7 O00311 1/20 0.35
DBF4 Q9UBU7 1/20 0.35
KDM4E B2RXH2 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
RAB9A P51151 1/20 0.34
LMNA P02545 1/20 0.34
DYRK1A Q13627 1/20 0.34
CES1 P23141 1/20 0.34
KMO O15229 2/20 0.33
SYK P43405 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17201544 0.81 AAK1 (0.36) CTSSCTSKAAK1KDM4EL3MBTL1
Trifluoroacetic Acid SCHEMBL17205294 0.78 CES1 (0.35) CTSSCTSKCDC7DBF4KDM4E
Trifluoroacetic Acid SCHEMBL17201561 0.77 KDM4E (0.54) KDM4EGLARAB9ALMNACES1
SCHEMBL17201501 0.76 AAK1 (0.41) CTSSCTSKAAK1KDM4EL3MBTL1
Trifluoroacetic Acid SCHEMBL17201525 0.76 HDAC6 (0.37) CTSSCTSKCDC7DBF4KDM4E
Trifluoroacetic Acid SCHEMBL17204972 0.75 KDM4E (0.39) CTSSCTSKCDC7DBF4KDM4E
SCHEMBL11889664 0.73 KDM4E (0.55) KDM4EGLAGAARAB9A
Trifluoroacetic Acid SCHEMBL27659159 0.72 CXCR4 (0.42) SORT1L3MBTL1
Trifluoroacetic Acid SCHEMBL17201540 0.72 CDC7 (0.44) CTSSCTSKAAK1CDC7DBF4
SCHEMBL17053175 0.69 WNT3A (0.48) CTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9725459-B2 3-oxo-tetrahydro-furo[3,2-B]pyrrol-4(5H)-yl) derivatives I GRUNENTHAL GMBH (DE) 2017-08-08 US disclosed
EP-3140309-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2017-03-15 EP disclosed
WO-2015161928-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2015-10-29 WO disclosed
US-20150307507-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307507-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I CTSK, OPRK1, CAT SORT1 4569/4885CTSS 33/4885CTSK 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.